Histone H2B ubiquitin ligase RNF20 is required for MLL -rearranged leukemia
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Mixed-lineage leukemia (MLL) fusions are potent oncogenes that initiate aggressive forms of acute leukemia. As aberrant transcriptional regulators, MLL-fusion proteins alter gene expression in hematopoietic cells through interactions with the histone H3 lysine 79 (H3K79) methyltransferase DOT1L. Notably, interference with MLL-fusion cofactors like DOT1L is an emerging therapeutic strategy in this disease. Here, we identify the histone H2B E3 ubiquitin ligase ring finger protein 20 (RNF20) as an additional chromatin regulator that is necessary for MLL-fusion-mediated leukemogenesis. Suppressing the expression of Rnf20 in diverse models of MLL-rearranged leukemia leads to inhibition of cell proliferation, under tissue culture conditions as well as in vivo. Rnf20 knockdown leads to reduced expression of MLL-fusion target genes, effects resembling Dot1l inhibition. Using ChIP-seq, we found that H2B ubiquitination is enriched in the body of MLL-fusion target genes, correlating with sites of H3K79 methylation and transcription elongation. Furthermore, Rnf20 is required to maintain local levels of H3K79 methylation by Dot1l at Hoxa9 and Meis1. These findings support a model whereby cotranscriptional recruitment of Rnf20 at MLL-fusion target genes leads to amplification of Dot1l-mediated H3K79 methylation, thereby rendering leukemia cells dependent on Rnf20 to maintain their oncogenic transcriptional program.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, H2B monoubiquitylation induced by the ubiquitin ligase RNF20 was necessary for leukemic cell growth in MLL-AF9 leukemia.47”
From USP22 deficiency leads to myeloid leukemia upon oncogenic Kras activation through a PU.1-dependent mechanism (2018) · cites this paper as [47]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625 · cited 1×
“Using gene set enrichment analysis (GSEA), we further verified a systematic suppression of MLL-AF9 target gene expression upon Rnf20 knockdown (35).”
MethodIn Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661 · cited 1×
“Targeting of other E3 ligase proteins with known drugs provides proof-ofprinciple that potent small-molecule inhibitors can be developed against this class of enzymes (46, 47).”
BackgroundFunctional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs
Rinn, J. L., Kertesz, M., Wang, J. K., Squazzo, S. L., Xu, X., Brugmann, S. A., Goodnough, L. H., Helms, J. A., Farnham, P. J., Segal, E., et al. (2007) · Cell · doi:10.1016/j.cell.2007.05.022 · Cited by 4,244
Java Treeview—extensible visualization of microarray data
Saldanha, A. J. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth349 · Cited by 2,991 · cited 1×
“Heat maps were generated with Java Tree View using a 20 reads per million per kilobase (RPKM) expression cutoff (49).”
MethodIdentification of a Primary Target of Thalidomide Teratogenicity
Ito, T., Ando, H., Suzuki, T., Ogura, T., Hotta, K., Imamura, Y., Yamaguchi, Y., & Handa, H. (2010) · Science · doi:10.1126/science.1177319 · Cited by 2,136 · cited 1×
“Targeting of other E3 ligase proteins with known drugs provides proof-ofprinciple that potent small-molecule inhibitors can be developed against this class of enzymes (46, 47).”
BackgroundRNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Zuber, J., Shi, J., Wang, E., Rappaport, A. R., Herrmann, H., Sison, E. A., Magoon, D., Qi, J., Blatt, K., Wunderlich, M., et al. (2011) · Nature · doi:10.1038/nature10334 · Cited by 1,870 · cited 12×
“Furthermore, RNF20 knockdown inhibited the proliferation of human AML lines harboring MLL translocations (MOLM-13, MV4-11, and THP-1), whereas the non–MLL-rearranged AML line CMK was affected to a lesser extent (Fig.”
BackgroundSelf-citationPrinciples of cancer therapy: oncogene and non-oncogene addiction
Luo, J., Solimini, N. L., & Elledge, S. J. (2009) · Cell · doi:10.1016/j.cell.2009.02.024 · Cited by 1,765 · cited 1×
“As a result, leukemia cells rely on RNF20 to maintain their leukemogenic gene expression program in a form of “nononcogene addiction” (42).”
BackgroundGenomic Maps and Comparative Analysis of Histone Modifications in Human and Mouse
Bernstein, B. E., Kamal, M., Lindblad-Toh, K., Bekiranov, S., Bailey, D. K., Huebert, D. J., McMahon, S., Karlsson, E. K., Kulbokas, E. J., Gingeras, T. R., et al. (2005) · Cell · doi:10.1016/j.cell.2005.01.001 · Cited by 1,527 · cited 1×
“It is interesting to note that the HOXA cluster possesses a unique chromatin architecture: a dense arrangement of genes in identical orientation, broad domains of histone modifications (43), extensive higher order chromatin interactions (44), and several interspersed long noncoding RNAs (45).”
BackgroundMLL translocations, histone modifications and leukaemia stem-cell development
Krivtsov, A. V., & Armstrong, S. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2253 · Cited by 1,249 · cited 17×
“Furthermore, RNF20 knockdown inhibited the proliferation of human AML lines harboring MLL translocations (MOLM-13, MV4-11, and THP-1), whereas the non–MLL-rearranged AML line CMK was affected to a lesser extent (Fig.”
BackgroundInfluentialShilatifard, A. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-051710-134100 · Cited by 1,091
Cited by
Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains
Shi, J., Wang, E., Milazzo, J. P., Wang, Z., Kinney, J. B., & Vakoc, C. R. (2015) · Nature Biotechnology · doi:10.1038/nbt.3235 · Cited by 761
Self-citationBorn to run: control of transcription elongation by RNA polymerase II
Chen, F. X., Smith, E. R., & Shilatifard, A. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0010-5 · Cited by 447
MLL-Rearranged Leukemias—An Update on Science and Clinical Approaches
Winters, A. C., & Bernt, K. M. (2017) · Frontiers in Pediatrics · doi:10.3389/fped.2017.00004 · Cited by 405
“H2Bub is required for the methylation of H3K79 mono- to di- and trimethylation (166), and knockdown of the H2B ubiquitin ligase RNF20 led to decrease in H3K79me2 mark at MLL target gene sites and in vitro and in vivo compromise of leukemia cell viability (167).”
BackgroundRoe, J.-S., Mercan, F., Rivera, K., Pappin, D. J., & Vakoc, C. R. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.04.011 · Cited by 337
“It has been previously proposed that BET inhibitors directly displace the MLL-fusion oncoprotein from chromatin; however, this model is contradicted by a lack of effect for BET inhibition on the expression of primary MLL-fusion target genes at the HOXA cluster (Dawson et al., 2011, 2014; Wang et al., 2013).”
BackgroundMethodSelf-citationMechanism of Cross-talk between H2B Ubiquitination and H3 Methylation by Dot1L
Worden, E. J., Hoffmann, N. A., Hicks, C. W., & Wolberger, C. (2019) · Cell · doi:10.1016/j.cell.2019.02.002 · Cited by 236
“Knockdown of human RNF20 or RNF40, which form the RNF20/40 heterodimeric E3 ligase that ubiquitinates H2BK120, leads to a decrease in H3K79 methylation in human cells (Wang et al., 2013; Zhu et al., 2005).”
BackgroundStructural Basis of Dot1L Stimulation by Histone H2B Lysine 120 Ubiquitination
Valencia-Sánchez, M. I., De Ioannes, P., Wang, M., Vasilyev, N., Chen, R., Nudler, E., Armache, J.-P., & Armache, K.-J. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.03.029 · Cited by 153
“In mammals, depletion of RNF20 (a component of E3 ligase for H2BK120) in leukemia cells leading to a global reduction in H2BK120Ub results in depletion of H3K79me2 at some genes (Wang et al., 2013a).”
Writing and reading H2B monoubiquitylation
Fuchs, G., & Oren, M. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.01.002 · Cited by 151
Histone H2B monoubiquitination: roles to play in human malignancy
Cole, A. J., Clifton-Bligh, R. J., & Marsh, D. J. (2014) · Endocrine Related Cancer · doi:10.1530/erc-14-0185 · Cited by 144
“…breast cancer (Zhang et al. 2011a), colorectal carcinoma (Liu et al. 2011), oesophageal cancer (Li et al. 2012), papillary thyroid carcinoma (Wang et al. 2013b), http://erc.endocrinology-journals.org q 2015 Society for Endocrinology DOI: 10.1530/ERC-14-0185 Printed in Great Britain gastric…”
BackgroundInfluentialTargeting DOT1L and HOX gene expression in MLL-rearranged leukemia and beyond
Chen, C.-W., & Armstrong, S. A. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.05.012 · Cited by 125
“H2B ubiquitinylation was found to facilitate DOT1L activity [141], and RNF20 is required to maintain gene expression and local levels of H3K79 methylation at HOXA9 and MEIS1 in MLL1rearranged leukemias [142].”
BackgroundH2B Lys34 Ubiquitination Induces Nucleosome Distortion to Stimulate Dot1L Activity
Ai, H., Sun, M., Liu, A., Sun, Z., Liu, T., Cao, L., Liang, L., Qu, Q., Li, Z., Deng, Z., et al. (2022) · Nature Chemical Biology · doi:10.1038/s41589-022-01067-7 · Cited by 123
Smurfs in Protein Homeostasis, Signaling, and Cancer
Koganti, P., Levy‐Cohen, G., & Blank, M. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00295 · Cited by 120
The upstreams and downstreams of H3K79 methylation by DOT1L
Vlaming, H., & van Leeuwen, F. (2016) · Chromosoma · doi:10.1007/s00412-015-0570-5 · Cited by 114
“Also RNF20, which can be recruited by the PAF complex, was required for high H3K79me2 at MLL-AF9 target genes (Wang et al. 2013).”
BackgroundZhang, X., Liu, D., Li, M., Cao, C., Wan, D., Xi, B., Li, W., Tan, J., Wang, J., Wu, Z., et al. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0400-8 · Cited by 101
Developing Targeted Therapies That Exploit Aberrant Histone Ubiquitination in Cancer
Jeusset, L. M., & McManus, K. J. (2019) · Cells · doi:10.3390/cells8020165 · Cited by 97
“RNF20 expression is required for proliferation of MLL rearrangement-driven leukemia [121] Not applicable”
BackgroundHe, L., Liu, X., Yang, J., Li, W., Liu, S., Liu, X., Yang, Z., Ren, J., Wang, Y., Shan, L., et al. (2018) · Cell Research · doi:10.1038/s41422-018-0079-6 · Cited by 96
Melo-Cardenas, J., Xu, Y., Wei, J., Tan, C., Kong, S., Gao, B., Montauti, E., Kirsammer, G., Licht, J. D., Yu, J., et al. (2018) · Blood · doi:10.1182/blood-2017-10-811760 · Cited by 84
Centromeric histone H2B monoubiquitination promotes noncoding transcription and chromatin integrity
Sadeghi, L., Siggens, L., Svensson, J. P., & Ekwall, K. (2014) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2776 · Cited by 87
shRNA screening identifies JMJD1C as being required for leukemia maintenance
Sroczyńska, P., Cruickshank, V. A., Bukowski, J., Miyagi, S., Bagger, F. O., Walfridsson, J., Schuster, M. B., Porse, B. T., & Helin, K. (2014) · Blood · doi:10.1182/blood-2013-08-522094 · Cited by 94
USP11 acts as a histone deubiquitinase functioning in chromatin reorganization during DNA repair
Ting, X., Xia, L., Yang, J., He, L., Si, W., Shang, Y., & Sun, L. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz726 · Cited by 88
The molecular mechanics of mixed lineage leukemia
Slany, R. K. (2016) · Oncogene · doi:10.1038/onc.2016.30 · Cited by 78
Targeting the histone H3 lysine 79 methyltransferase DOT1L in MLL-rearranged leukemias
Yi, Y., & Ge, S. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01251-1 · Cited by 75
“Targeting histone H2B ubiquitin ligase RNF20 In particular, histone H2B E3 ubiquitin ligase ring finger protein 20 (RNF20)-mediated H2B ubiquitination is reported to be enriched in the body of MLL fusion target genes such as HOXA9 and MEIS1, correlating with sites of H3K79 methylation by DOT1L and transcription elonga…”
BackgroundCooperative gene activation by AF4 and DOT1L drives MLL-rearranged leukemia
Okuda, H., Stanojević, B., Kanai, A., Kawamura, T., Takahashi, S., Matsui, H., Takaori‐Kondo, A., & Yokoyama, A. (2017) · Journal of Clinical Investigation · doi:10.1172/jci91406 · Cited by 81
Castro, P. G., Roon, E. H. J. V., Pinhanços, S. S., Trentin, L., Schneider, P., Kerstjens, M. J., Kronnie, G. T., Heidenreich, O. T., Pieters, R., & Stam, R. W. (2017) · Leukemia · doi:10.1038/leu.2017.216 · Cited by 75
Duan, Y., Huo, D., Gao, J., Wu, H., Ye, Z., Liu, Z., Zhang, K., Shan, L., Zhou, X., Wang, Y., et al. (2016) · Nature Communications · doi:10.1038/ncomms12648 · Cited by 69
“RNF20 or RNF40 knockdown inhibits the growth of different types of mouse cells 28 as well as human LNCaP cells 29 , and RNF20 depletion suppresses leukaemia progression in vivo 30 .”
Small Molecule Control of Chromatin Remodeling
Finley, A., & Copeland, R. A. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.07.024 · Cited by 71
Pharmacological Modulation of Ubiquitin-Proteasome Pathways in Oncogenic Signaling
Sharma, A., Khan, H., Singh, T. G., Grewal, A. K., Najda, A., Kawecka-Radomska, M., Kamel, M. S., Altyar, A. E., & Abdel‐Daim, M. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111971 · Cited by 68
CBP mediated DOT1L acetylation confers DOT1L stability and promotes cancer metastasis
Liu, C., Yang, Q., Zhu, Q., Lu, X., Li, M., Hou, T., Li, Z., Tang, M., Li, Y., Wang, H., et al. (2020) · Theranostics · doi:10.7150/thno.39013 · Cited by 62
“For example, histone 2B ubiquitination (H2Bub) can interact directly or indirectly with DOT1L to alter chromatin structure and facilitate DOT1L-mediated H3K79 methylation [23, 41].”
BackgroundTarcic, O., Granit, R. Z., Pateras, I. S., Masury, H., Maly, B., Zwang, Y., Yarden, Y., Gorgoulis, V. G., Pikarsky, E., Ben‐Porath, I., et al. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2016.126 · Cited by 67
Li, B. E., & Ernst, P. (2014) · Experimental Hematology · doi:10.1016/j.exphem.2014.09.006 · Cited by 62
USP38 Couples Histone Ubiquitination and Methylation via KDM5B to Resolve Inflammation
Zhao, Z., Su, Z., Liang, P., Liu, D., Yang, S., Wu, Y., Ma, L., Feng, J., Zhang, X., Wu, C., et al. (2020) · Advanced Science · doi:10.1002/advs.202002680 · Cited by 65
Oss-Ronen, L., Sarusi, T., & Cohen, I. (2022) · Cells · doi:10.3390/cells11152404 · Cited by 62
“The depletion of RNF20 leads to a reduction in DOTL1mediated H3K79me3, while the overexpression of RNF20 or the in vitro use of nucleosomes bearing H2BK120ub stimulates DOTL1 catalytic activity [34,130,134].”
BackgroundHistone Monoubiquitination in Chromatin Remodelling: Focus on the Histone H2B Interactome and Cancer
Marsh, D. J., Ma, Y., & Dickson, K.-A. (2020) · Cancers · doi:10.3390/cancers12113462 · Cited by 62
“RNF20 has also been identified as necessary for proliferation, both in vitro in mixed-lineage leukemia (MLL)-rearranged human acute myeloid leukemia (AML) cell lines and in vivo, being important for disease progression in a genetically engineered mouse model of AML [74].”
BackgroundJarome, T. J., Perez, G., Webb, W. M., Hatch, K. M., Navabpour, S., Musaus, M., Farrell, K., Hauser, R. M., McFadden, T., Martin, K., et al. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.12.029 · Cited by 57
Zheng, S., Li, D., Lü, Z., Liu, G., Wang, M., Xing, P., Wang, M., Dong, Y., Wang, X., Li, J., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky918 · Cited by 51
Bivalent Epigenetic Control of Oncofetal Gene Expression in Cancer
Zaidi, S. K., Frietze, S. E., Gordon, J. A. R., Heath, J. L., Messier, T., Hong, D., Boyd, J. R., Kang, M., Imbalzano, A. N., Lian, J. B., et al. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00352-17 · Cited by 53
“It has additionally been found that H2B E3 ligase RNF20 is required for MLL-rearranged leukemogenesis, wherein there are increased levels of H3Bub in MLL target genes correlating with sites of H3K79me2, making RNF20 an attractive epigenetic target in MLL-rearranged leukemias (171).”
BackgroundGoru, S. K., Kadakol, A., Pandey, A., Malek, V., Sharma, N., & Gaikwad, A. B. (2016) · Biochemical Journal · doi:10.1042/bcj20160595 · Cited by 48
Xiao, Y., Tang, Z., Fu, X., Yin, J., Liang, Y., Li, C., Li, H., Tian, Q., Roeder, R. G., & Wang, G. (2015) · The EMBO Journal · doi:10.15252/embj.201591279 · Cited by 48
“…that orchestrates multiple steps involved in gene expression, including transcription initiation, elongation, termination, and mRNA processing (Donner et al , 2010; Mukundan & Ansari, 2011; Takahashi et al , 2011; Huang et al , 2012; Galbraith et al , 2013; Wang et al , 2013b; Yin & Wang, 2014).”
InfluentialSelf-citationRole of RNF20 in cancer development and progression – a comprehensive review
Sethi, G., Shanmugam, M. K., Arfuso, F., & Kumar, A. P. (2018) · Bioscience Reports · doi:10.1042/bsr20171287 · Cited by 45
“In a study by Wang et al. (2013) [93] they reported the role of RNF20 in the pathogenesis of MLL-fusion leukemia. They found that RNF20 is an additional chromatin regulator that is necessary for MLL-fusion-mediated leukemogenesis and that suppression of RNF20 in leukemia cells leads to inhibition of cell proliferation…”
BackgroundLive-cell epigenome manipulation by synthetic histone acetylation catalyst system
Fujiwara, Y., Yamanashi, Y., Fujimura, A., Sato, Y., Kujirai, T., Kurumizaka, H., Kimurâ, H., Yamatsugu, K., Kawashima, S. A., & Kanai, M. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2019554118 · Cited by 45
“It is known that the presence of H2B ubiquitination on nucleosomes can enhance the activity of Dot1L catalyzing H3K79 methylation (22), and both Dot1L and the H2B E3 ubiquitin ligase ring finger protein 20 (RNF20) are required for MLL-rearranged leukemia (23, 24).”
BackgroundFlexibility in crosstalk between H2B ubiquitination and H3 methylation in vivo
Vlaming, H., van Welsem, T., de Graaf, E. L., Ontoso, D., Altelaar, M. A. F., San-Segundo, P. A., Heck, A. J. R., & van Leeuwen, F. (2014) · EMBO Reports · doi:10.15252/embr.201438793 · Cited by 49
“As proliferation in MLL-rearranged leukemias depends on RNF20, DOT1L and MLL1, this trans-histone crosstalk may have a role in cancer [6–8].”
BackgroundUbiquitin-dependent regulation of transcription in development and disease
Mark, K. G., & Rapé, M. (2021) · EMBO Reports · doi:10.15252/embr.202051078 · Cited by 41
“While defects in H2B monoubiquitylation block cell fate specification, altered levels of ubiquitylated H2B are observed in many cancers (Wang et al, 2013; Fuchs & Oren, 2014; Dickson et al, 2016; Tarcic et al, 2016).”
USP38 Couples Histone Ubiquitination and Methylation via KDM5B to Resolve Inflammation
Zhao, Z., Su, Z., Liang, P., Liu, D., Yang, S., Wu, Y., Ma, L., Feng, J., Zhang, X., Wu, C., et al. (2021) · Advanced Science · doi:10.1002/advs.202101964 · Cited by 43
RE-IIBP Methylates H3K79 and Induces MEIS1-mediated Apoptosis via H2BK120 Ubiquitination by RNF20
Park, J. W., Kim, K., Kim, J., Chae, Y., Jeong, O.-S., & Seo, S. (2015) · Scientific Reports · doi:10.1038/srep12485 · Cited by 34
The interaction of ENL with PAF1 mitigates polycomb silencing and facilitates murine leukemogenesis
Hetzner, K., García-Cuéllar, M.-P., Büttner, C., & Slany, R. K. (2017) · Blood · doi:10.1182/blood-2017-11-815035 · Cited by 36
Song, G., Shi, L., Guo, Y., Yu, L., Wang, L., Zhang, X., Li, L., Han, Y., Ren, X., Guo, Q., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6551 · Cited by 38
“Furthermore, demethylation has been observed in genes involved in the differentiation of specific cell lines [36].”
BackgroundSethi, G., Shanmugam, M. K., & Kumar, A. P. (2017) · Bioscience Reports · doi:10.1042/bsr20171270 · Cited by 32
The role of DOT1L in the proliferation and prognosis of gastric cancer
Song, Z., Wei, Z., Wang, Q., Zhang, X., Tao, X., Wu, N., Liu, X., & Qian, J. (2020) · Bioscience Reports · doi:10.1042/bsr20193515 · Cited by 36
RetractedMLL fusion proteins and transcriptional control
Slany, R. K. (2020) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2020.194503 · Cited by 33
Foglizzo, M., Middleton, A. J., & Day, C. L. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.07.025 · Cited by 35
Spolverini, A., Fuchs, G., Bublik, D. R., & Oren, M. (2017) · Oncogene · doi:10.1038/onc.2017.187 · Cited by 33
Villarreal, A., & Vogel, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136867 · Cited by 29
Simultaneous paralogue knockout using a CRISPR-concatemer in mouse small intestinal organoids
Andersson-Rolf, A., Merenda, A., Mustata, R. C., Li, T., Dietmann, S., & Koo, B. (2016) · Developmental Biology · doi:10.1016/j.ydbio.2016.10.016 · Cited by 28
“CRISPR technology has made genome editing both simple and fast and has facilitated genome-wide knockout screens in mouse and human cells (Koike-Yusa et al., 2014; Leeb et al., 2014; Wang et al., 2013).”
BackgroundProteasome inhibition targets the KMT2A transcriptional complex in acute lymphoblastic leukemia
Kamens, J. L., Nance, S., Koss, C., Xu, B., Cotton, A., Lam, J. W., Garfinkle, E. A. R., Nallagatla, P., Smith, A. M. R., Mitchell, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36370-x · Cited by 24
The MLL/SET family and haematopoiesis
Antunes, E., & Ottersbach, K. (2020) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2020.194579 · Cited by 26
Role of H2B mono-ubiquitination in the initiation and progression of cancer
Zhou, S., Cai, Y., Liu, X., Jin, L., Wang, X., Ma, W., & Zhang, T. (2021) · Bulletin du Cancer · doi:10.1016/j.bulcan.2020.12.007 · Cited by 23
Spangler, C. J., Yadav, S. P., Li, D., Geil, C. N., Smith, C. B., Wang, G. G., Lee, T.-H., & McGinty, R. K. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110369 · Cited by 22
“Much like H3K79 methylation, H2BK120ub is present at HOX genes targeted by DOT1L in leukemia, and the H2BK120-targeting ubiquitin E3 ligase is required for MLL-fusion-induced leukemogenesis (Wang et al., 2013; Zhu et al., 2005).”
BackgroundPan, Y., An, N., Deng, X., Zhang, Q., & Du, X. (2020) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2020.102490 · Cited by 21
Dasgupta, A., Mondal, P., Dalui, S., Das, C., & Roy, S. (2021) · FEBS Journal · doi:10.1111/febs.16262 · Cited by 23
Krause, L. M. F., Japp, A. S., Krause, A., Mooster, J. L., Chopra, M., Müschen, M., & Bohlander, S. K. (2014) · Scientific Reports · doi:10.1038/srep06565 · Cited by 20
Alterations of Histone Modifications in Cancer
Hosseini, A., & Minucci, S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812215-0.00006-6 · Cited by 33
CRISPR–ChIP reveals selective regulation of H3K79me2 by Menin in MLL leukemia
Gilan, O., Talarmain, L., Bell, C. C., Neville, D., Knezevic, K., Ferguson, D. T., Boudes, M., Chan, Y.-C., Davidovich, C., Lam, E. Y. N., et al. (2023) · Nature Structural & Molecular Biology · doi:10.1038/s41594-023-01087-4 · Cited by 19
Structure of the human Bre1 complex bound to the nucleosome
Onishi, S., Uchiyama, K., Sato, K., Okada, C., Kobayashi, S., Hamada, K., Nishizawa, T., Nureki, O., Ogata, K., & Sengoku, T. (2024) · Nature Communications · doi:10.1038/s41467-024-46910-8 · Cited by 19
“However, a previous study on MLL-rearranged leukemia suggested they have asymmetric functions 41 .”
InfluentialTargeted Drug Discovery for Pediatric Leukemia
Napper, A. D., & Watson, V. G. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00170 · Cited by 23
“…of DOT1L is markedly enhanced by interaction of the enzyme with ubiquitinylated histone 2B (McGinty et al., 2008, 2009), it has now been reported that proliferation of MLL-R leukemia cells was suppressed by knockdown of the ubiquitin ligase RNF20 that ubiquitinylates histone 2B (Wang et al., 2013).”
BackgroundMolecular Mechanisms of Epigenetic Regulators as Activatable Targets in Cancer Theranostics
Li, Y., Li, Z., & Zhu, W. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867324666170921101947 · Cited by 21
Structure of the human Bre1 complex bound to the nucleosome
(2023) · doi:10.1101/2023.03.31.535082 · Cited by 19
Jeusset, L. M., & McManus, K. J. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.12.007 · Cited by 20
Histone lysine modifying enzymes and their critical roles in DNA double-strand break repair
Zhang, J., Lu, X., MoghaddamKohi, S., Shi, L., Xu, X., & Zhu, W. (2021) · DNA repair · doi:10.1016/j.dnarep.2021.103206 · Cited by 18
The H2B ubiquitin-protein ligase RNF40 is required for somatic cell reprogramming
Xie, W., Miehe, M., Laufer, S. D., & Johnsen, S. A. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2482-4 · Cited by 19
Fatima, I., Ahmad, R., Barman, S., Gowrikumar, S., Pravoverov, K., Primeaux, M., Fisher, K. W., Singh, A. B., & Dhawan, P. (2024) · British Journal of Cancer · doi:10.1038/s41416-023-02570-x · Cited by 21
Zhang, M., Su, L., Wang, W., Li, C., Liang, Q., Ji, F., & Jiao, J. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111350 · Cited by 18
Lyu, Y., Yang, Y., Talwar, V., Lu, H., Chen, C. O., Salman, S., Wicks, E. E., Huang, T. Y.-T., Drehmer, D., Wang, Y., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113972 · Cited by 20
RNF20 promotes the polyubiquitination and proteasome-dependent degradation of AP-2α protein
Ren, P., Sheng, Z., Wang, Y., Yi, X., Zhou, Q., Zhou, J., Xiang, S., Hu, X., & Zhang, J. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt136 · Cited by 14
Sun, N., Zhong, X., Wang, S., Zeng, K., Sun, H., Sun, G., Zou, R., Liu, W., Liu, W., Lin, L., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.103108 · Cited by 14
Jeusset, L. M., Guppy, B. J., Lichtensztejn, Z., McDonald, D., & McManus, K. J. (2021) · Cancers · doi:10.3390/cancers13051043 · Cited by 13
“This observation suggests that the global increases in H2Bub1 observed in several cancers [82,83] may be a novel mechanism underlying intermediate CIN levels that contribute to worse patient outcomes.”
BackgroundDoxorubicin, a DNA intercalator, inhibits transcription elongation
Tempel, M., Green, K., Prajapati, D., Duaqui, A., Norouzi, M., Sattarifard, H., Ashraf, A. B., Wu, E., Zovoilis, A., Lakowski, T. M., et al. (2025) · Biochemistry and Cell Biology · doi:10.1139/bcb-2024-0264 · Cited by 16
Murine breast cancers disorganize the liver transcriptome in a zonated manner
Vandenbon, A., Mizuno, R., Konishi, R., Onishi, M., Masuda, K., Kobayashi, Y., Kawamoto, H., Suzuki, A., He, C., Nakamura, Y., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-04479-w · Cited by 14
Self-citationPathania, A. S. (2023) · Cancers · doi:10.3390/cancers15102833 · Cited by 17
Restoring MLL reactivates latent tumor suppression-mediated vulnerability to proteasome inhibitors
Ge, M., Li, D., Qiao, Z., Sun, Y., Kang, T., Zhu, S., Wang, S., Xiao, H., Zhao, C., Shen, S., et al. (2020) · Oncogene · doi:10.1038/s41388-020-01408-7 · Cited by 11
Epigenetic Control of Infant B Cell Precursor Acute Lymphoblastic Leukemia
de Barrios, O., & Parra, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063127 · Cited by 12
“Importantly, the knockdown of KMT2A-AF9 fusion protein in t(9;11)-rearranged ALL cells triggers a concomitant downregulation of both H3K79me2 and H2Bub marks, indicating that these two events, which cooperate in RNA polymerase II transcription elongation [81], are somehow interconnected [136].”
BackgroundDysregulation of HOXA genes in acute myeloid leukemia and targeted therapy
Huang, W., Zhang, F., Zhang, Z., Wang, Q., & Chen, S. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-01200-4 · Cited by 12
“The histone H2B E3 ubiquitin ligase RNF20 maintains local levels of H3K79 methylation by Dot1l at Hoxa9 and Meis1, and its suppression reduces KMT2A-r target gene expression 107 .”
Histone PTM Crosstalk Stimulates Dot1 Methyltransferase Activity
Cutler, J. A., Perner, F., & Armstrong, S. A. (2021) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2021.04.001 · Cited by 9
Therapeutic targeting potential of chromatin-associated proteins in MLL-rearranged acute leukemia
Xu, X., & Schneider, B. (2018) · Cellular Oncology · doi:10.1007/s13402-018-0414-4 · Cited by 8
Ubiquitin proteasome system (UPS): a crucial determinant of the epigenetic landscape in cancer
Roy, S., & Ghosh, M. K. (2025) · Epigenomics · doi:10.1080/17501911.2025.2501524 · Cited by 9
Genome-wide DNA methylation pattern in whole blood of patients with coal-burning arsenic poisoning
Wei, S., Wang, W., Liu, S., Sun, B., Zeng, Q., Wang, G., Luo, P., & Zhang, A. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.114323 · Cited by 7
Chemical catalyst manipulating cancer epigenome and transcription
Yamanashi, Y., Takamaru, S., Okabe, A., Kaito, S., Azumaya, Y., Kamimura, Y. R., Yamatsugu, K., Kujirai, T., Kurumizaka, H., Iwama, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56204-2 · Cited by 8
Mesuraca, M., Amodio, N., Chiarella, E., Scicchitano, S., Aloisio, A., Codispoti, B., Lucchino, V., Montalcini, Y., Bond, H. M., & Morrone, G. (2018) · Molecules · doi:10.3390/molecules23082060 · Cited by 7
“Among these are the receptor tyrosine kinase FLT3 [55,56,58,59]; HoxA9, one of the prominent target genes of MLL [60,61]; the GTPase Rac1 [55,62,63]; a variety of epigenetic modulators including the H3K79 methyltransferase DOT1L [64–67], the AAA+ ATPase RUVBL2 [68], the histone 2B ubiquitin ligase, RNF20 [69], and the…”
BackgroundThe H2Bub1-deposition complex is required for human and mouse cardiogenesis
Barish, S., Berg, K., Drozd, J., Berglund-Brown, I., Khizir, L., Wasson, L. K., Seidman, C. E., Seidman, J. G., Chen, S., & Brueckner, M. K. (2023) · Development · doi:10.1242/dev.201899 · Cited by 8
Alterations of histone modifications in cancer
Saber-Ayad, M. M., Ramadan, W. S. H., & El‐Awady, R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18661-5.00018-x · Cited by 7
The Relationship Between DOT1L, Histone H3 Methylation, and Genome Stability in Cancer
Guppy, B. J., Jeusset, L. M., & McManus, K. J. (2017) · Current Molecular Biology Reports · doi:10.1007/s40610-017-0051-0 · Cited by 5
Zeisig, B. B., & So, C. W. E. (2015) · Springer eBooks · doi:10.1007/978-3-319-19983-2_11 · Cited by 6
Jansari, S., Blandau, A., Prokakis, E., Grimm, D. T., Naßl, A. M., Küffer, S., Möbius, W., Dullin, C., Ramos‐Gomes, F., Schüürhuis, L., et al. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02279-9 · Cited by 6
“In contrast, tumor-supportive roles have been described in hepatocellular carcinoma [41], and MLL-rearranged leukemia [42].”
Insights into active intragenic enhancers
Yang, Y., Dai, Z., & Dai, X. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.05.160 · Cited by 4
Navabpour, S., Farrell, K., Kincaid, S. E., Omar, N., Musaus, M., Yu, L., Xie, H., & Jarome, T. J. (2024) · Learning & Memory · doi:10.1101/lm.053912.123 · Cited by 4
“Monoubiquitination of histone H2B, while less abundant than other modi fi cations, is widely associated with chromatin dynamics and transcriptional regulation (Sun and Allis 2002; Wang et al. 2013; Wojcik et al. 2018; Deng et al. 2020).”
Wang, J., Liu, Q., Zhao, S., Shao, Q., Fu, F., Zhang, K., Ma, J., Wang, Z., Yan, Y., Wang, H., et al. (2026) · PLoS Pathogens · doi:10.1371/journal.ppat.1013890 · Cited by 3
Maintaining chromosome and genome stability by the RPA–RNF20–SNF2H cascade
Driscoll, G., & Yan, S. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2306455120 · Cited by 3
Decoding Ubiquitin Modifications by Mass Spectrometry
Gong, Y., & Dai, L. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-981-97-7288-9_1 · Cited by 3
Xu, P., Ye, G., Xu, X., Liu, Z., Yu, W., Guan, Z., Su, Z., Lin, J., Che, Y., Zeng, Y., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.06.015 · Cited by 3
“The current focus revolves around modifications such as H3K4 methylation and H3K79 methylation, primarily associated with the activation of gene transcription 17,18 .”
BET Bromodomain Inhibition as a Therapeutic Approach in Hematological Malignancies
Vakoc, C. R. (2015) · Springer eBooks · doi:10.1007/978-3-319-18102-8_9 · Cited by 3
“JQ1/I-BET also failed to reduce expression of Hoxa9 in the MLLfusion leukemia background (Wang et al. 2013), which is the most well-validated direct target of this oncoprotein (Krivtsov and Armstrong 2007).”
BackgroundSelf-citationProcesses that Regulate the Ubiquitination of Chromatin and Chromatin-Associated Proteins
Hare, A. E., & Parvin, J. D. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.82567 · Cited by 4
Histone modification and personalized epigenomics in cancer
Ramazi, S., Dadzadi, M., Sahafnejad, Z., & Allahverdi, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23802-4.00009-0 · Cited by 4
Metadata
- Authors
- Wang, E., Kawaoka, S., Yu, M., Shi, J., Ni, T., Yang, W., Zhu, J., Roeder, R. G., & Vakoc, C. R.
- Affiliations
- Cold Spring Harbor Laboratory (US)
- Rockefeller University (US)
- National Institutes of Health (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2013-02-14
- Volume
- 110
- Issue
- 10
- Pages
- 3901-3906
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3593849
- OpenAlex
- W2014880942
- Cited by
- 121
- References
- 50
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 6 · 2023: 10 · 2022: 8 · 2021: 15 · 2020: 11 · 2019: 9 · 2018: 12 · 2017: 10 · 2016: 6 · 2015: 8 · 2014: 8 · 2013: 4
- FWCI
- 6.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Funders
- F. M. Kirby Foundation
- Leukemia and Lymphoma Society
- Edward P. Evans Foundation
- James N. Kirby Foundation
- National Institutes of Health (5p30ca045508-35)
- National Cancer Institute (P30-CA045508, CA45508)
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- RNF20, MLL rearrangement, MLL fusion proteins, DOT1L, H3K79 methylation, histone H2B ubiquitination, E3 ubiquitin ligase, acute leukemia, transcriptional regulation, HOXA9, MEIS1, transcription elongation, leukemogenesis, chromatin regulation
- MeSH terms
- Animals, Base Sequence, DNA, Neoplasm, Histones, Humans, Models, Biological, Molecular Sequence Data, Histone-Lysine N-Methyltransferase, Proto-Oncogenes, Gene Rearrangement, Leukemia, Myeloid, Acute, Oncogene Proteins, Fusion, RNA, Small Interfering, Ubiquitin-Protein Ligases, Cell Line, Tumor, Mice, Myeloid-Lymphoid Leukemia Protein, Gene Knockdown Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.